Vodafone Group Plc (ADR) (NASDAQ:VOD) selling operations in Angola, Zambia, Côte d’Ivoire, Nigeria and Ghana

South-African telecom company Vodacom, African arm of Vodafone Group Plc (ADR) (NASDAQ:VOD), announce it is selling operations in Angola, Zambia, Côte d’Ivoire, Nigeria and Ghana. In the first country, the company plans to divest its Business Africa unit to Internet Technologies Angola (ITA). The selling cost is not disclosed but the agreement is subject to approval from market regulatory authorities.

Vodafone Group Plc (ADR) (NASDAQ:VOD), a Technology sector firm, traded 2.42 Million shares in last trading session with closing price of $16.26 per share. Company gross margin stands at 30.90% whereas its return on investment (ROI) is -2.10%. Stock value has moved between $15.49 – 25.41 in last one year. Analyst’s mean target price for Vodafone Group Plc (ADR) (NASDAQ:VOD) is $24.80 while analysts mean recommendation is 1.00. VOD EPS growth this year is -202.70%. 

On last trading day, Novartis AG (NYSE:NVS) shares closed at $90.94 per share. NVS market capitalization is 227751.96 with beta of 0.61. Analyst’s mean target price for Novartis AG (NYSE:NVS) is $99.50 whereas analysts mean recommendation is 1.50. Its weekly performance is -1.55% while year to date (YTD) performance is 18.32%. 

In last session Partner Communications Company Ltd. (NASDAQ:PTNR) traded 1131 shares and was closed at $4.17. Analyst’s mean target price for PTNR is $22.00. Company is -25.54% away from its 52 week high and is moving 24.44% ahead of its 52 week low. PTNR Gross Margin is 16.70% and its return on assets is 1.10%. Partner Communications Company Ltd. (NASDAQ:PTNR) quarterly performance is 14.25% while its price to sale ratio is 0.78. 

Allergan plc (NYSE:AGN), a Healthcare sector firm, traded 6.76 Million shares on last trading day with closing price of $166.01 per share. Company gross margin stands at 86.20% whereas its return on investment (ROI) is -4.80%. Stock value has moved between $114.49 – 197.63 in last one year. Analyst’s mean target price for Allergan plc (NYSE:AGN) is $177.60 while analysts mean recommendation is 2.20. AGN EPS growth this year is 24.90%.